GRAYBUG
GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.
GRAYBUG
Social Links:
Industry:
Biotechnology Health Care Medical Wellness
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.graybug.vision
Total Employee:
51+
Status:
Active
Contact:
650-487-2800
Email Addresses:
[email protected]
Total Funding:
129.24 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Pound Sterling Japanese Yen WP Engine
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - GrayBug
Deerfield Capital Management
Deerfield Capital Management investment in Series C - GrayBug
C-Bridge Capital
C-Bridge Capital investment in Series C - GrayBug
Clarus Ventures
Clarus Ventures investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - GrayBug
OrbiMed
OrbiMed investment in Series B - GrayBug
Deerfield
Deerfield investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - GrayBug
Maryland Venture Fund
Maryland Venture Fund investment in Series A - GrayBug
More informations about "GrayBug"
Graybug Vision, Inc. - AnnualReports.com
Graybug is a biopharmaceutical company focused on developing transformative medicines for ocular diseases. Founded in 2011 based on technology licensed from the Johns Hopkins University School of Medicine, Graybug has offices in …See details»
Mission Statement, Vision, & Core Values (2024) of Graybug …
[relinking] Home Overview Mission Vision Values An Overview of Graybug Vision, Inc. (GRAY)General Summary of Graybug Vision, Inc. Graybug Vision, Inc. (NASDAQ: GRAY) is a …See details»
Graybug Vision, Inc. (GRAY): history, ownership, mission, how it …
[relinking] Home History Owners Mission How It Works How It Makes Money Graybug Vision, Inc. (GRAY) InformationA Brief History of Graybug Vision, Inc. (GRAY) Graybug Vision, Inc. is a …See details»
Graybug Vision - VentureRadar
Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve. …See details»
Graybug Announces Name and Trading Symbol Change
About Graybug Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for ocular diseases. Founded in 2011 based on technology licensed …See details»
Graybug Vision, Inc. - Drug pipelines, Patents, Clinical trials
Explore Graybug Vision, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 43 news, and 1 literature, Disease Domain:Immune System ...See details»
Graybug Vision Inc (GRAY-Q) Profile - The Globe and Mail
See the company profile for Graybug Vision Inc (GRAY-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
GrayBug Company Profile - Office Locations, Competitors ... - Craft
GrayBug has 5 employees across 2 locations and $128.49 m in total funding,. See insights on GrayBug including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Graybug Vision, Inc. (GRAY) 10K Annual Reports & 10Q SEC Filings
Inside Graybug Vision, Inc.'s 10-K Annual Report: Financial - Expense Highlight. Components of Operating Results Research and Development Expenses Our research and development …See details»
GB-701 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 8, 2024 BALTIMORE, May 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing …See details»
CalciMedica acquires GrayBug - 2022-11-21 - Crunchbase
Nov 21, 2022 CalciMedica acquires GrayBug on 2022-11-21 for $35000000. Search Crunchbase. Start Free Trial . Chrome Extension ... GrayBug acquired by CalciMedica . Save . …See details»
All Eyes on Graybug Vision! Here’s Why! - Avise Analytics
Jun 14, 2021 Graybug Vision is a clinical-stage biopharmaceutical company seeking to find treatment solutions to combat combat vision—threatening diseases including macular …See details»
Graybug Vision, Inc. (GRAY): VRIO Analysis [10-2024 Updated]
Organization. Graybug Vision has established comprehensive recruitment and training programs. The company's investment in employee training was reported at $2.3 million in 2022, which …See details»
Graybug Vision (GRAY) Stock Price, News & Analysis - MarketBeat
3 days ago Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The …See details»
Graybug Vision announces pipeline expansion - Ophthalmology …
Mar 30, 2022 Graybug Vision Inc. today announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (wet AMD), GB-401 in primary open-angle …See details»
Lake Ridge Vision Center Inc. - Eye Care Clinic in Woodbridge, VA
Lake Ridge Vision Center Inc. is a Optometrist Center in Woodbridge, Virginia. It is situated at 12444 Dillingham Sq, Woodbridge and its contact number is 703-680-4323. The authorized …See details»
TOTAL VISION OPTOMETRIC CENTER - Updated December 2024
TOTAL VISION OPTOMETRIC CENTER, 4565 Daisy Reid Ave, Ste 108, Woodbridge, VA 22192, Mon - 9:00 am - 6:00 pm, Tue - 9:00 am - 7:30 pm, Wed - 9:00 am - 6:00 pm, Thu - 9:30 am - …See details»
Debbie Oakley Professional Organizer | Woodbridge VA - Facebook
Professional organization services can be delivered efficiently and... Debbie Oakley Professional Organizer, Woodbridge, Virginia. 59 likes · 4 were here. Professional organization services …See details»
Vision Magazine Woodbridge - Facebook
Vision Magazine Woodbridge. 1,633 likes. The colourful, vibrant and exciting local magazine for Woodbridge, Melton and Martlesham. Delivered dSee details»